Ophthalmology Times Europeophthalmology news, features, events and interviews in cataract, refractive, glaucoma, retina and much more.MICS: the European picture- September 1, 2008 Statistics published for the first time by OTE provide a true picture of the number of European surgeons practising MICS. Interviews with European experts highlight the reasons why all cataract surgeons should adopt the technique, whilst a product showcase catalogues the instruments and lenses currently available for today's MICS surgeon.http://www.oteurope.com/ophthalmologytimeseurope/Cataract+Clinical/MICS-the-European-pictu... Hydrophilic vs hydrophobic: which is the better option- September 1, 2008 Dr Christophe Chassain believes blue-blocking square-edged hydrophilic lenses are just as safe as their hydrophobic counterpartshttp://www.oteurope.com/ophthalmologytimeseurope/Cataract+Clinical/Hydrophilic-vs-hydropho... Artiflex Toric: will it hit the mark- September 1, 2008 Promising early results indicate new phakic IOL could win the support of surgeons, according to Dr Camille Budo.http://www.oteurope.com/ophthalmologytimeseurope/Refractive+clinical/Artiflex-Toric-will-i... How many Europeans are affected by VKC- September 1, 2008 The prevalence of vernal keratoconjunctivitis (VKC) in Europe is 3.2 per 10000 inhabitants, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/How-many-Europeans-are-affect... Twenty-year treatment trends- September 1, 2008 Ophthalmologists today are more likely to begin treatment to reduce intraocular pressure (IOP) at lower levels than twenty years ago, according to a study published in the Journal of Glaucoma, August 2008.http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Twenty-year-treatment-trend... seeingBerlin- September 1, 2008 A travel guide to help you get the most out of your stay in Berlin during the XXVI ESCRS congress.http://www.oteurope.com/ophthalmologytimeseurope/seeingBerlin/ArticleStandard/Article/deta... Pfizer discontinues Asian development of glaucoma compound- September 1, 2008 Pfizer has announced that it does not plan to begin a Phase III trial of its experimental compound PF-03187207 for glaucoma and ocular hypertension in Asia.http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Pfizer-discontinues-Asian-d... Ocular blood flow alters with age- September 1, 2008 There is a large variation in the blood flow to the macula across a 24-hour period in old, but not young, eyes, according to results published in the August issue of the Journal of Glaucoma.http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Ocular-blood-flow-alters-wi... Strabismus gene discovery- September 1, 2008 The genetic mutations responsible for Duane's retraction syndrome (DRS) and strabismus have been identified, according to a study published online as a Science Express Report.http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Strabismus-gene-discovery/Art... Avastin gains further support- September 1, 2008 Avastin (bevacizumab) is effective in the arrest of angiogenesis at several stages, according to a study published online ahead of print by Acta Ophthalmologica.http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Avastin-gains-further-support... |